Bioengineering strategy uses immune-protected beta cell transplant to advance type 1 diabetes care

Regenerative medicine holds the extraordinary promise that future patients in need of new cells, tissues or organs will no longer have to rely on donors. Organ shortages and cell type mismatches will become past problems, replaced by safe, on-demand options for anyone who needs a transplant.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup